These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22531293)

  • 1. Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents.
    Schirmbeck F; Nieratschker V; Frank J; Englisch S; Rausch F; Meyer-Lindenberg A; Rietschel M; Zink M
    Psychiatr Genet; 2012 Oct; 22(5):245-52. PubMed ID: 22531293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms.
    Kwon JS; Joo YH; Nam HJ; Lim M; Cho EY; Jung MH; Choi JS; Kim B; Kang DH; Oh S; Park T; Hong KS
    Arch Gen Psychiatry; 2009 Nov; 66(11):1233-41. PubMed ID: 19884611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.
    Dickel DE; Veenstra-VanderWeele J; Cox NJ; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
    Arch Gen Psychiatry; 2006 Jul; 63(7):778-85. PubMed ID: 16818867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms.
    Cai J; Zhang W; Yi Z; Lu W; Wu Z; Chen J; Yu S; Fang Y; Zhang C
    Psychopharmacology (Berl); 2013 Nov; 230(1):49-55. PubMed ID: 23660601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms.
    Ryu S; Oh S; Cho EY; Nam HJ; Yoo JH; Park T; Joo YH; Kwon JS; Hong KS
    Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(8):949-59. PubMed ID: 21990008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.
    Schirmbeck F; Esslinger C; Rausch F; Englisch S; Meyer-Lindenberg A; Zink M
    Psychol Med; 2011 Nov; 41(11):2361-73. PubMed ID: 21466748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.
    Stewart SE; Fagerness JA; Platko J; Smoller JW; Scharf JM; Illmann C; Jenike E; Chabane N; Leboyer M; Delorme R; Jenike MA; Pauls DL
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1027-33. PubMed ID: 17894418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder.
    Abdolhosseinzadeh S; Sina M; Ahmadiani A; Asadi S; Shams J
    J Clin Pharm Ther; 2019 Feb; 44(1):39-48. PubMed ID: 30315580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder.
    Real E; Gratacòs M; Labad J; Alonso P; Escaramís G; Segalàs C; Subirà M; López-Solà C; Estivill X; Menchón JM
    Pharmacogenomics J; 2013 Oct; 13(5):470-5. PubMed ID: 22776887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obsessive-Compulsive Symptoms in a Sample of Patients with Chronic Schizophrenia Under Clozapine Treatment].
    Schreiter S; Hasan A; Majic T; Wullschleger A; Schouler-Ocak M; Bermpohl F; Gutwinski S
    Fortschr Neurol Psychiatr; 2016 Nov; 84(11):675-681. PubMed ID: 27846652
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of the candidate gene SLC1A1 and obsessive-compulsive disorder in Han Chinese population.
    Wu H; Wang X; Yu S; Wang D; Chen J; Jiang K; Zhu L; Xiao Z; Fralick D
    Psychiatry Res; 2013 Oct; 209(3):737-9. PubMed ID: 23411042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single nucleotide polymorphism in SLC1A1 gene is associated with age of onset of obsessive-compulsive disorder.
    Dallaspezia S; Mazza M; Lorenzi C; Benedetti F; Smeraldi E
    Eur Psychiatry; 2014 Jun; 29(5):301-3. PubMed ID: 24768158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.
    Arnold PD; Sicard T; Burroughs E; Richter MA; Kennedy JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):769-76. PubMed ID: 16818866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.
    Wendland JR; Moya PR; Timpano KR; Anavitarte AP; Kruse MR; Wheaton MG; Ren-Patterson RF; Murphy DL
    Arch Gen Psychiatry; 2009 Apr; 66(4):408-16. PubMed ID: 19349310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.
    Fonseka TM; Richter MA; Müller DJ
    Curr Psychiatry Rep; 2014 Nov; 16(11):510. PubMed ID: 25256097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between glutamate transporter gene polymorphisms and obsessive-compulsive disorder/trait empathy in a Korean population.
    Kim HW; Kang JI; Hwang EH; Kim SJ
    PLoS One; 2018; 13(1):e0190593. PubMed ID: 29304071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on.
    Gahr M; Rehbaum K; Connemann BJ
    Pharmacopsychiatry; 2014 May; 47(3):118-20. PubMed ID: 24846087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom structure of antipsychotic-induced obsessive compulsive symptoms in schizophrenia patients.
    Kim JH; Ryu S; Nam HJ; Lim M; Baek JH; Joo YH; Kwon JS; Ha TH; Hong KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):75-9. PubMed ID: 22617280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate transporter gene polymorphisms and obsessive-compulsive disorder: A case-control association study.
    de Salles Andrade JB; Giori IG; Melo-Felippe FB; Vieira-Fonseca T; Fontenelle LF; Kohlrausch FB
    J Clin Neurosci; 2019 Apr; 62():53-59. PubMed ID: 30661718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.